title: A double-blind, controlled comparison of piperacillin and cefoxitin in the prevention of postoperative infection in patients undergoing cesarean section.
abstract: Data are presented from a randomized, double-blind multicenter trial (six study sites, involving 346 patients) in which piperacillin was compared with cefoxitin as a prophylactic agent for patients undergoing cesarean section. One hundred and sixty-nine patients received piperacillin and 177 received cefoxitin; in each instance, the total dosage was 6 grams. Strict criteria were used to evaluate safety and efficacy. The courses of all of the patients were evaluable for safety and 183 courses were evaluable for efficacy (136 efficacy-evaluable courses were from patients treated with piperacillin and 147, from those treated with cefoxitin). Postoperative infection was prevented in 89 per cent of the patients treated with piperacillin and in 93 per cent of the those treated with cefoxitin. The difference was not statistically significant. The data from each of the individual study sites, as well as the pooled data, indicated that the short term perioperative administration of piperacillin in patients undergoing a cesarean section was as safe and effective as cefoxitin with regard to prophylactic response, duration of hospitalization and the usage of other systemic antibiotics.
authors.forename: B B
authors.initials: BB
authors.lastname: Benigno
authors.forename: L C
authors.initials: LC
authors.lastname: Ford
authors.forename: W D
authors.initials: WD
authors.lastname: Lawrence
authors.forename: W J
authors.initials: WJ
authors.lastname: Ledger
authors.forename: F W
authors.initials: FW
authors.lastname: Ling
authors.forename: S G
authors.initials: SG
authors.lastname: McNeeley
mesh_terms: D000293:Adolescent; D000328:Adult; D002440:Cefoxitin / Q000009:adverse effects / Q000627:therapeutic use*; D002585:Cesarean Section; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D017053:Infection Control; D010878:Piperacillin / Q000009:adverse effects / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control; D011247:Pregnancy; D011292:Premedication; D011897:Random Allocation; D013246:Sterilization, Tubal
chemical_list: D002440:Cefoxitin; D010878:Piperacillin